What is the ticker symbol for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals trades under the ticker NRBO on NASDAQ.

What sector does NeuroBo Pharmaceuticals operate in?

NeuroBo Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NRBO in a portfolio?

PortView shows NRBO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

NeuroBo Pharmaceuticals (NRBO) Stock Analysis

NASDAQHealthcareBiotechnology

$2.36

1-year price historyRange $1.60 – $6.52

What NeuroBo Pharmaceuticals does

NeuroBo Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm committed to advancing treatments for a spectrum of challenging conditions, encompassing neurodegenerative disorders, infectious diseases, and cardiometabolic ailments. The company's diverse pipeline includes several investigational therapies: ANA001, an orally administered formulation of niclosamide, is currently progressing through Phase 2/3 clinical trials to treat individuals with moderate coronavirus disease (COVID-19). NB-01 is being developed to alleviate the discomfort associated with painful diabetic neuropathy. NB-02 targets the management of cognitive decline symptoms and seeks to alter the course of neurodegenerative conditions specifically linked to the malfunction of tau protein. Gemcabene is also part of their portfolio, under investigation for its potential in acute COVID-19 indications. NeuroBo Pharmaceuticals, Inc. maintains its corporate headquarters in Boston, Massachusetts.

Key metrics

Market cap

$20.33M

P/E (TTM)

-0.55

EPS (TTM)

$-4.29

Beta

-0.28

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.00

200-day avg

$0.00

52-week high

$2.36

52-week low

$2.36

CEO

Hyung-Heon Kim

ETFs linked to NRBO

Broad-market and Healthcare sector ETFs an investor holding NeuroBo Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NRBO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NRBO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for NeuroBo Pharmaceuticals?: NeuroBo Pharmaceuticals trades under the ticker NRBO on NASDAQ.
Which exchange is NRBO listed on?: NRBO is listed on NASDAQ.
What sector does NeuroBo Pharmaceuticals operate in?: NeuroBo Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NRBO in a portfolio?: PortView shows NRBO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.